Development of CDX-527: a bispecific antibody combining PD-1 blockade and CD27 costimulation for cancer immunotherapy
2020 · Cancer Immunology Immunotherapy · 29 citations
https://doi.org/10.1007/s00262-020-02610-y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
1.2K
Citations
12
h-index
13
i10-index
Andrea Crocker is an academic researcher from Celldex Therapeutics (United States). The author has contributed to research in topics: Monoclonal and Polyclonal Antibodies Research & Immunotherapy and Immune Responses & Cancer Immunotherapy and Biomarkers. The author has an h-index of 12, co-authored 37 publications.
https://doi.org/10.1007/s00262-020-02610-y
https://doi.org/10.1016/j.jaci.2024.12.713
Click to start Chat